A sub-Saharan African perspective of diabetes

被引:136
作者
Gill, G. V. [1 ]
Mbanya, J. -C. [2 ]
Ramaiya, K. L. [3 ]
Tesfaye, S. [4 ]
机构
[1] Univ Liverpool Liverpool Sch Trop Med, Clin Div, Liverpool L3 5QA, Merseyside, England
[2] Univ Yaounde, Dept Endocrinol & Diabet, Yaounde, Cameroon
[3] Shree Hindu Mandal Hosp, Dept Med, Dar Es Salaam, Tanzania
[4] Royal Hallamshire Hosp, Dept Endocrinol & Diabet, Sheffield S10 2JF, S Yorkshire, England
关键词
Africa; Atypical diabetes; Diabetes mellitus; Diabetic complications; Healthcare delivery; Malnutrition-related diabetes mellitus; Mortality; Type; 1; diabetes; 2; ISLET-CELL ANTIBODIES; NONCOMMUNICABLE DISEASE; MACROVASCULAR DISEASE; HEALTH-CARE; C-PEPTIDE; MELLITUS; INSULIN; KETOACIDOSIS; MORTALITY; PREVALENCE;
D O I
10.1007/s00125-008-1167-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is an important and increasing cause of morbidity and mortality in sub-Saharan Africa. Accurate epidemiological studies are often logistically and financially difficult, but processes of rural-urban migration and epidemiological transition are certainly increasing the prevalence of type 2 diabetes. Type 1 disease is relatively rare, although this may be related to high mortality. This diabetic subgroup appears to present at a later age (by about a decade) than in Western countries. Variant forms of diabetes are also described in the continent; notably 'atypical, ketosis-prone' diabetes, and malnutrition-related diabetes mellitus. These types sometimes make the distinction between type 1 and type 2 diabetes difficult. Interestingly, this is also a current experience in the developed world. As more detailed and reliable complication studies emerge, it is increasingly apparent that African diabetes is associated with a high complication burden, which is both difficult to treat and prevent. More optimistically, a number of intervention studies and twinning projects are showing real benefits in varying locations. Future improvements depend on practical and sustainable support, coupled with local acceptance of diabetes as a major threat to the future health and quality of life of sub-Saharan Africans.
引用
收藏
页码:8 / 16
页数:9
相关论文
共 88 条
[1]  
ABBAS ZG, 2000, DIABETES INT, V10, P52
[2]   THE CLINICAL AND HORMONAL (C-PEPTIDE AND GLUCAGON) PROFILE AND LIABILITY TO KETOACIDOSIS DURING NUTRITIONAL REHABILITATION IN ETHIOPIAN PATIENTS WITH MALNUTRITION-RELATED DIABETES-MELLITUS [J].
ABDULKADIR, J ;
MENGESHA, B ;
GEBRIEL, ZW ;
KEEN, H ;
WORKU, Y ;
GEBRE, P ;
BEKELE, A ;
URGA, K ;
TADDESSE, AS .
DIABETOLOGIA, 1990, 33 (04) :222-227
[3]  
Acheampong J., 2000, Diabetes International, V10, P81
[4]  
ADADEVOH BK, 1968, T ROY SOC TROP MED H, V62, P528
[5]  
Adetuyibi A, 1975, West Afr J Pharmacol Drug Res, V2, P97
[6]  
Afifi A, 2004, East Mediterr Health J, V10, P620
[7]  
Ahren B, 1985, Diabet Med, V2, P262
[8]  
Aizawa T, 1997, DIABETIC MED, V14, P989
[9]  
Akanji A O, 1990, West Afr J Med, V9, P1
[10]  
Alebiosu C O, 2003, West Afr J Med, V22, P152